Currently, two clinical studies, approved by the Spanish Agency of Medicines and Healthcare Products for the treatment of Alzheimer’s disease are being carried out at EuroEspes Medical Center, with new drugs:
STUDY 1:
"An Aleatory, Double-Blind Clinical Trial, to Compare the Safety and Efficacy of CEREBROLYSIN, ARICEPT (Donepezyl) and a Combined Therapy in Patients with Probable Alzheimer’s Disease ".
STUDY 2:
"A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Efficacy of Two Different Doses of PHENSERINE-tartrate in Patients with slight to moderate Alzheimer’s Disease - Phenserine/APP and Aß"
Patients with Probable Alzheimer’s Disease who fulfill the requirements demanded may take part in these clinical studies with new drugs. Participation in said clinical studies is voluntary and free of charge.
If you need more information, please contact with Dr. Antón Álvarez, R&D Director, Department of Neuropharmacology
Telephone contac:+34 981-780505
E mail: neurofarma@euroespes.com
